Large gap with delayed quotes
|
Last quote
12/27/2024 -
17:20:00
|
Bid
12/27/2024 -
15:59:59
|
Bid Volume |
Ask
12/27/2024 -
15:59:59
|
Ask Volume |
|---|---|---|---|---|
|
8.28
-0.19
(
-2.24% )
|
8.28
|
5,300 |
8.29
|
4,900 |
Analysis date: 24.12.2024
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 30.07.2024.
Interest
Weak
Weak
Weak interest since 24.12.2024.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 06.12.2024 at a price of 8.94.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, at its current price the stock is moderately undervalued.
MT Tech Trend
Negative
Negative
The forty day Medium Term Technical Trend is negative since 11.10.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is
4wk Rel Perf
-9.57%
-9.57%
The four week relative underperformance versus SP500 is 9.57%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 1.97%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 6.24%.
Mkt Cap in $bn
1.38
1.38
With a market capitalization <$2bn, NOVAVAX is considered a small-cap stock.
G/PE Ratio
22.27
22.27
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
6.38
6.38
The estimated PE is for the year 2027.
LT Growth
142.17%
142.17%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
4
4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
242
242
For 1% of index variation, the stock varies on average by 2.42%.
Correlation
0.20
0.20
Stock movements are totally independent of index variations.
Value at Risk
7.37
7.37
The value at risk is estimated at USD 7.37. The risk is therefore 86.62%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
19.09.2014
19.09.2014